Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01652716. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Exenatide Twice Daily in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To compare the effect on glycemic control (HbA1c) of exenatide suspension administered once weekly to that achieved by exenatide administered twice daily for 28 weeks in subjects with type 2 diabetes mellitus. To examine the long-term (52 weeks of treatment) safety and effect on glucose control of exenatide suspension administered once weekly in subjects with type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT01652716
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 377 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2013 (Type not available)
- Primary completion
- Aug 2014 (Actual)
- Completion
- Aug 2014 (Actual)
- Last update posted
- Jul 3, 2018
2013 – 2014
United States locations
- U.S. sites
- 58
- U.S. states
- 28
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Muscle Shoals | Alabama | 35662 | — |
| Research Site | Mesa | Arizona | 85206 | — |
| Research Site | Phoenix | Arizona | 85020 | — |
| Research Site | Little Rock | Arkansas | 72205 | — |
| Research Site | Escondido | California | 92026 | — |
| Research Site | Garden Grove | California | 92844 | — |
| Research Site | Lomita | California | 90717 | — |
| Research Site | Los Angeles | California | 90015 | — |
| Research Site | Santa Ana | California | 92705 | — |
| Research Site | Spring Valley | California | 91978 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | Coral Gables | Florida | 33134 | — |
| Research Site | DeLand | Florida | 32720 | — |
| Research Site | Kissimmee | Florida | 34741 | — |
| Research Site | Miami | Florida | 33156 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Oviedo | Florida | 32765 | — |
| Research Site | Palm Harbor | Florida | 34684 | — |
| Research Site | Ponte Vedra | Florida | 32081 | — |
| Research Site | Chicago | Illinois | 60607 | — |
| Research Site | Chicago | Illinois | 60616 | — |
| Research Site | Lexington | Kentucky | 40503 | — |
| Research Site | Paducah | Kentucky | 42003 | — |
| Research Site | Lake Charles | Louisiana | 70601 | — |
| Research Site | Columbia | Maryland | 21045 | — |
| Research Site | Elkridge | Maryland | 21075 | — |
| Research Site | Hyattsville | Maryland | 20782 | — |
| Research Site | New Bedford | Massachusetts | 02740 | — |
| Research Site | Detroit | Michigan | 48202 | — |
| Research Site | Troy | Michigan | 48098 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Port Gibson | Mississippi | 39150 | — |
| Research Site | St Louis | Missouri | 63128 | — |
| Research Site | Butte | Montana | 59701 | — |
| Research Site | Henderson | Nevada | 89052 | — |
| Research Site | Endwell | New York | 13760 | — |
| Research Site | New Windsor | New York | 12553 | — |
| Research Site | Greensboro | North Carolina | 27408 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Cincinnati | Ohio | 45227 | — |
| Research Site | Columbus | Ohio | 43213 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Portland | Oregon | 97239 | — |
| Research Site | Harleysville | Pennsylvania | 19438 | — |
| Research Site | Charleston | South Carolina | 29407 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Houston | Texas | 77062 | — |
| Research Site | San Antonio | Texas | 78205 | — |
| Research Site | Murray | Utah | 84123 | — |
| Research Site | Salt Lake City | Utah | 84107 | — |
| Research Site | Manassas | Virginia | 20110 | — |
| Research Site | Norfolk | Virginia | 23502 | — |
| Research Site | Richmond | Virginia | 23294 | — |
| Research Site | Olympia | Washington | 98502 | — |
| Research Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01652716, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 3, 2018 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01652716 live on ClinicalTrials.gov.